AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event
News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]
Public Acceptance of COVID-19 Vaccine Faces Many Hurdles
Story Highlights Even before a vaccine against COVID-19 has been introduced to the public in the U.S., expectations for it are low. Dr. Anthony Fauci warns that a COVID-19 vaccine is not expected to be either long-lasting or more than 50 to 60 percent effective. Citing experience with other vaccines, a COVID-19 vaccine is not […]
Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine
A recent poll conducted by the Associated Press’s NORC Center for Public Affairs Research found that 20 percent of Americans anticipate that a COVID-19 vaccine will be available to the public before the end of 2020, while 61 percent expect it during 2021. Only 17 percent believe it will take longer than that to develop.1 […]
Moral Implications of Human Fetal Cell Lines in Vaccine Production
One commonly cited reason for claiming a religious vaccine exemption has to do with the fact that some vaccines are made using aborted fetal cell lines. As reported in an April 26, 2019, article in Christianity Today:1 For certain Christians, the decision of whether to vaccinate comes down to the origins of the vaccines themselves. Some […]